I. Contreras-Hernández

发表

Genotype-Environment Interaction Analysis of NQO1, CYP2E1, and NAT2 Polymorphisms and the Risk of Childhood Acute Lymphoblastic Leukemia: A Report From the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia

A. Hidalgo-Miranda, J. Fernández-López, J. Mejía-Aranguré, 2020, Frontiers in Oncology.

Antiprolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus

I. Contreras-Hernández, A. Leaños-Miranda, 2002, Endocrine.

Direct medical costs for partial refractory epilepsy in Mexico.

F. García-Contreras, J. Mould-Quevedo, I. Contreras-Hernández, 2006, Archives of medical research.

[Evaluation of health-related quality of life in patients with non-Hodgkin lymphoma and colorectal cancer at different stages, attending the Mexican Institute of Social Security].

G. Morgan-Villela, Margarita-Arimatea Díaz-Cortés, J. Mould-Quevedo, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[Evaluation of patient satisfaction with the quality of health care received within the EORTC IN-PATSAT32 trial by patients with breast and colorectal cancer, and non-Hodgkin lymphoma at different stages. Correlation with sociodemographic characteristics, comorbidities and other procedural variables

G. Morgan-Villela, Margarita-Arimatea Díaz-Cortés, J. Mould-Quevedo, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Direct medical costs of treating Mexican children under 2 years of age with respiratory syncytial virus

M. Villasís-Keever, J. Mould-Quevedo, G. Salinas-Escudero, 2012 .

Empirical anti-mycotic treatment of immunocompromised patients with neutropenia and persistent fever with suspicion of systemic aspergillosis: Cost-effectiveness study in Mexico

J. Mejía-Aranguré, J. Mould-Quevedo, I. Contreras-Hernández, 2009 .

Antimycotic treatment for immunocompromised patients with neutropenia and persistent fever with suspicion of systemic aspergillosis : a cost-effective analysis in Mexico

J. Mejía-Aranguré, J. Mould-Quevedo, I. Contreras-Hernández, 2009 .

A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours

M. Villasís-Keever, I Contreras-Hernández, J F Mould-Quevedo, 2008, British Journal of Cancer.

Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women.

I. Contreras-Hernández, A. Leaños-Miranda, L. Manuel-Apolinar, 2001, The Journal of clinical endocrinology and metabolism.

Cost-effectiveness simulation analysis of schizophrenia at the Instituto Mexicano del Seguro Social. Assessment of typical and atypical antipsychotics

J. Mejía-Aranguré, J. Mould-Quevedo, I. Contreras-Hernández, 2009 .

Association Analysis Between the Functional Single Nucleotide Variants in miR-146a, miR-196a-2, miR-499a, and miR-612 With Acute Lymphoblastic Leukemia

A. Hidalgo-Miranda, J. Mejía-Aranguré, D. A. Duarte-Rodríguez, 2021, Frontiers in Oncology.

Direct costs associated with the appropriateness of hospital stay in elderly population

T. Juárez-Cedillo, J. Mould-Quevedo, C. García-Peña, 2009, BMC health services research.

The hospital appropriateness evaluation protocol in elderly patients: a technique to evaluate admission and hospital stay.

T. Juárez-Cedillo, J. Mould-Quevedo, C. García-Peña, 2008, Scandinavian journal of caring sciences.

Cost Effectiveness and Resource Allocation Cost-effectiveness Analysis for Joint Pain Treatment in Patients with Osteoarthritis Treated at the Instituto Mexicano Del Seguro Social (imss): Comparison of Nonsteroidal Anti-inflammatory Drugs (nsaids) vs. Cyclooxygenase-2 Selective Inhibitors

J. Mejía-Aranguré, M. Goycochea-Robles, J. Mould-Quevedo, 2008 .

[Quality of life in Mexican women with breast cancer at different stages and its association with sociodemographic characteristics, comorbidities and procedural factors at the Mexican Institute of Social Security].

G. Morgan-Villela, Margarita-Arimatea Díaz-Cortés, J. Mould-Quevedo, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico.

J. Chancellor, D. Becker, J. Mould-Quevedo, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[Diagnostic yield of various urine tests in urinary tract infections].

I. Contreras-Hernández, A. Leaños-Miranda, R. Camacho, 1996, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Redes Transversales de Investigación en Salud: estrategia para la medicina traslacional

I. Contreras-Hernández, L. C. Bonifaz-Alfonzo, 2022, Revista medica del Instituto Mexicano del Seguro Social.

Cost-effectiveness simulation analysis of schizophrenia at the Instituto Mexicano del Seguro Social: Assessment of typical and atypical antipsychotics.

J. Mejía-Aranguré, J. M. Mejía-Arangure, J. Mould-Quevedo, 2009, Revista de psiquiatria y salud mental.

J. Mould-Quevedo, Victoria María, I. Contreras-Hernández, 2008 .

Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors

J. Mejía-Aranguré, M. Goycochea-Robles, J. Mould-Quevedo, 2008, Cost effectiveness and resource allocation : C/E.